Engineering a Thymosin Alpha-1 Fusion Protein for Enhanced Immune Stimulation

A fusion protein combining thymosin alpha-1 with B-lymphocyte stimulator (BLyS) was expressed in E. coli, potentially combining T-cell and B-cell immune enhancement in a single molecule for comprehensive immunotherapy.

Shen, Qiong et al.·Biotechnology letters·2005·Preliminary Evidencein-vitro
RPEP-01083In VitroPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Thymosin alpha-1-cBLyS fusion protein expressed in E. coli combined T-cell immune enhancement (thymosin alpha-1) with B-cell stimulation (BLyS), creating a dual-arm immunostimulatory molecule for potential comprehensive immunotherapy.

Key Numbers

How They Did This

in-vitro study on thymosin-alpha-1, immune-function.

Why This Research Matters

Relevant for thymosin-alpha-1, immune-function, peptide-design.

The Bigger Picture

Advances peptide/biomarker research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Thymosin alpha-1-cBLyS fusion protein expressed in E. coli combined T-cell immune enhancement (thymosin alpha-1) with B-cell stimulation (BLyS), creat
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.
Published In:
Biotechnology letters, 27(3), 143-8 (2005)
Database ID:
RPEP-01083

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Engineering a Thymosin Alpha-1 Fusion Protein for Enhanced Immune Stimulation

What was found?

A fusion protein combining thymosin alpha-1 with B-lymphocyte stimulator (BLyS) was expressed in E. coli, potentially combining T-cell and B-cell immune enhancement in a single molecule for comprehensive immunotherapy.

Read More on RethinkPeptides

Cite This Study

RPEP-01083·https://rethinkpeptides.com/research/RPEP-01083

APA

Shen, Qiong; Tian, Ruiyang; Ma, Wenzhe; Yuan, Qinsheng; Gong, Yi. (2005). Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.. Biotechnology letters, 27(3), 143-8.

MLA

Shen, Qiong, et al. "Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.." Biotechnology letters, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Construction and expression of a new fusion protein, thymosi..." RPEP-01083. Retrieved from https://rethinkpeptides.com/research/shen-2005-construction-and-expression-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.